RANKINGS

Key list: leading companies by R&D expenditure in Japan

Powered by 

This month our pharma industry key list brings you the 15 leading companies in Japan by R&D expenditure, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of November 2020.

Company name

Entity type    

Number of employeesR&D expenditure ($m)

Takeda Pharmaceutical Co Ltd

Public49,5782,818

Daiichi Sankyo Co Ltd

Public15,0001,934

Astellas Pharma Inc

Public15,8831,878

Otsuka Holdings Co Ltd

Public32,9921,584

Eisai Co Ltd

Public10,683941

Mitsubishi Tanabe Pharma Corp

Private6,987585

Shionogi & Co Ltd

Public5,233541

Ono Pharmaceutical Co Ltd

Public3,560519

Kyowa Kirin Co Ltd

Public5,267444

Teijin Ltd

Public20,075320

Santen Pharmaceutical Co Ltd

Public4,108206

Taisho Pharmaceutical Holdings Co Ltd

Public9,354192

Mochida Pharmaceutical Co Ltd

Public1,617137

Nippon Shinyaku Co Ltd

Public2,026134

Hisamitsu Pharmaceutical Co Inc

Public2,745130
Go to article: Home | The logistics of delivering a global vaccineGo to article: In this issueGo to article: ContentsGo to article: MimotopesGo to article: SHL MedicalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: SwiftpakGo to article: CommentGo to article: Long HCC pipeline marks change for a previously stagnant marketGo to article: Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacyGo to article: Blockchain-enabled hospital can provide real-world dataGo to article: The increasing influence of industry sponsors along the pandemic timelineGo to article: Digitalisation in pharmaceutical manufacturingGo to article: VEGA AustraliaGo to article: KugelmeiersGo to article: Unither PharmaceuticalsGo to article: In DepthGo to article: Special delivery: the logistics of curing Covid-19 Go to article: Will there ever be an HIV vaccine?Go to article: Predicting Covid-19 vaccine approvals with OpylGo to article: Unequal access: understanding cancer treatment disparity in EuropeGo to article: ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?Go to article: Q&A: investing in innovative biotechs with Novo VenturesGo to article: Gold standard: why are Phase III trials so critical?Go to article: Brewprint: using yeast to make plant-based drugsGo to article: Air FranceGo to article: Zenatek Company Insight Go to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue